Unilife (NSDQ:UNIS) and Amgen (NSDQ:AMGN) are giving themselves another week to come to an agreement on whether their deal for Unilife’s wearable injector technology will be exclusive to Amgen. UNIS shares jumped last month after the companies revealed the initial deal, which called for a non-refundable $15 million deposit from Amgen, which will use Unilife’s wearable injector devices for some […]
Unilife Corp.
Amgen, Unilife extend talks on exclusivity deal
Unilife (NSDQ:UNIS) and Amgen (NSDQ:AMGN) are giving themselves to the end of the week to come to an agreement on whether their deal for Unilife’s wearable injector technology will be exclusive to Amgen. UNIS shares jumped last month after the companies revealed the initial deal, which called for a non-refundable $15 million deposit from Amgen, which will use Unilife’s […]
Unilife jumps on $15m Amgen injector deal
Unilife (NSDQ:UNIS) saw shares jump over 50% after signing a $15m deal with Amgen (NSDQ:AMGN) that positions the company to offer Amgen its wearable injector devices. The strategic partnership included a non-refundable $15 million deposit from Amgen, who will use Unilife’s wearable injector devices along with “certain large volume drug products”. The deal also included a perpetual […]
Unilife taps CEO Shortall for loan to forestall default
Unilife (NSDQ:UNIS) yesterday said it tapped chairman & CEO Alan Shortall for a loan so it could avoid defaulting on its $60 million debt with OrbiMed. Wayne, Pa.-based Unilife said it borrowed $600,000 from Shortall so it could maintain the $5 million cash balance required by the OrbiMed loan and still make a payment on the loan. […]
Unilife amends Novartis supply deal
Unilife (NSDQ:UNIS) said today it amended a clinical supply agreement with Novartis (NYSE:NVS) to supply it with additional batches of Unilife’s drug delivery device for use with a novel investigational drug. The agreement, originally signed in 2013 to supply them with the deliver devices for a targeted early-stage pipeline drug, was also amended to include an […]
Losses widening, Unilife pares workforce by 17%
Unilife (NSDQ:UNIS) yesterday said it plans to lay off about 50 workers, or roughly 17% of its workforce, after reporting wider losses for its fiscal 4th quarter and full-year 2015 and missing expectations on Wall Street. Saying it now has a lineup of products to cover its target markets, York, Pa.-based Unilife said it’s looking to […]
Reva Medical snags ex-MDT’er Groves for CEO | Personnel Moves
Reva Medical (ASX:RVA) said last week it picked up ex-Medtronic (NYSE:MDT) divisional veep Regina Groves as its new CEO. Groves was vice president and GM of the atrial fibrillation solutions, cardiac rhythm and heart failure division at Medtronic. During her time there, she helped the company strategize a re-entry into the catheter-based atrial fibrillation ablation market, the […]
Unilife debuts 1st insulin patch pump, financing plans, prelim earnings
Unilife (NSDQ:UNIS) released a slew of announcements yesterday, saying it launched a new insulin patch pump, a new financing strategy and released preliminary fiscal Q4 earnings. The York, Penn.-based company said it launched the Imperium instant insulin patch pump, which it claims is the world’s 1st instant patch pump. The Imperium is a pre-filled insulin pump that […]
Ex-FDA chief Hamburg moves to Institute of Medicine | Personnel Moves
Dr. Margaret Hamburg, who resigned as FDA commissioner in February, was named foreign secretary of the U.S. Institute of Medicine this week.
Hamburg spent 6 years leading the federal safety watchdog, overseeing a massive revamp of its medical device, drug, food and tobacco regulation.
Amniox Medical taps ex-Smith & Nephew honcho Dugan for CEO | Personnel Moves
Unilife signs production deal with Flextronics
